SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'IH5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BSX_A_T3A1_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 221 ILE A 222 ARG A 228 MET A 256 MET A 259 ALA A 263 LEU A 276 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.66A	1bsxA-1navA: 37.4	1bsxA-1navA: 83.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BSX_A_T3A1_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 MET A 259 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.44A	1bsxA-1navA: 37.4	1bsxA-1navA: 83.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BSX_B_T3B2_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 221 ILE A 222 ARG A 228 MET A 256 MET A 259 ALA A 263 LEU A 276 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.66A	1bsxB-1navA: 37.5	1bsxB-1navA: 83.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BSX_B_T3B2_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 MET A 259 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.44A	1bsxB-1navA: 37.5	1bsxB-1navA: 83.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XZX_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 221 ILE A 222 ALA A 225 ARG A 228 MET A 256 MET A 259 LEU A 276 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 (-4.0A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.69A	1xzxX-1navA: 37.1	1xzxX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XZX_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	7 / 12	ILE A 222 ALA A 225 MET A 259 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.25A	1xzxX-1navA: 37.1	1xzxX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Y0X_X_T44X500_1 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	11 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 MET A 259 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401 PHE A 405	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A) None	0.71A	1y0xX-1navA: 37.3	1y0xX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Y0X_X_T44X500_1 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	9 / 12	ILE A 222 ALA A 225 ARG A 266 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401 PHE A 405	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) None IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A) None	0.79A	1y0xX-1navA: 37.3	1y0xX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Y0X_X_T44X500_1 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	7 / 12	ILE A 222 ALA A 225 MET A 259 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.27A	1y0xX-1navA: 37.3	1y0xX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1Y0X_X_T44X500_2 (THYROID HORMONE RECEPTOR BETA-1)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	4 / 5	ILE A 221 SER A 260 ARG A 262 LEU A 276	None IH5 A 600 ( 4.0A) None IH5 A 600 (-4.0A)	0.21A	1y0xX-1navA: 37.3	1y0xX-1navA: 83.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2H77_A_T3A1_1 (THRA PROTEIN)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 MET A 259 ALA A 263 LEU A 276 SER A 277 LEU A 292 ILE A 299 HIS A 381 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-4.4A)	0.71A	2h77A-1navA: 37.8	2h77A-1navA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2H77_A_T3A1_1 (THRA PROTEIN)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 ALA A 225 MET A 259 LEU A 292 ILE A 377 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-4.4A)	1.35A	2h77A-1navA: 37.8	2h77A-1navA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2H79_A_T3A1_1 (THRA PROTEIN)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	11 / 12	ILE A 221 ILE A 222 ALA A 225 MET A 256 ALA A 263 LEU A 276 SER A 277 LEU A 292 ILE A 299 HIS A 381 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-3.6A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-4.4A)	0.42A	2h79A-1navA: 37.5	2h79A-1navA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2H79_A_T3A1_1 (THRA PROTEIN)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	11 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 ALA A 263 LEU A 276 SER A 277 LEU A 292 ILE A 299 HIS A 381 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-4.4A)	0.68A	2h79A-1navA: 37.5	2h79A-1navA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GWS_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	7 / 12	ALA A 225 ARG A 228 ALA A 263 LEU A 276 LEU A 292 ILE A 299 PHE A 405	IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None	1.49A	3gwsX-1navA: 37.2	3gwsX-1navA: 83.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GWS_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 221 ILE A 222 ALA A 225 ARG A 228 MET A 256 MET A 259 ALA A 263 LEU A 276 LEU A 292 ILE A 299 HIS A 381 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-4.4A)	0.66A	3gwsX-1navA: 37.2	3gwsX-1navA: 83.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GWS_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 ALA A 225 MET A 259 LEU A 292 ILE A 377 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) None IH5 A 600 (-4.4A)	1.31A	3gwsX-1navA: 37.2	3gwsX-1navA: 83.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_B_SAMB301_0 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	5 / 12	GLY A 303 ILE A 299 ASP A 268 LEU A 274 ARG A 266	None IH5 A 600 (-4.7A) None None None	1.33A	3iv6B-1navA: undetectable	3iv6B-1navA: 23.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UVV_A_T3A501_1 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 221 ILE A 222 ALA A 225 MET A 256 ALA A 263 LEU A 276 LEU A 287 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	None IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-3.6A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) None IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.51A	3uvvA-1navA: 36.4	3uvvA-1navA: 90.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UVV_A_T3A501_2 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	3 / 3	ARG A 228 MET A 259 ARG A 262	IH5 A 600 (-4.2A) IH5 A 600 (-4.7A) None	0.49A	3uvvA-1navA: 36.4	3uvvA-1navA: 90.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNW_A_T3A501_1 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 ALA A 263 LEU A 276 SER A 277 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.77A	4lnwA-1navA: 37.5	4lnwA-1navA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNW_A_T3A501_1 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 ALA A 225 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.28A	4lnwA-1navA: 37.5	4lnwA-1navA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNW_A_T3A501_2 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	3 / 3	ILE A 221 MET A 259 ARG A 262	None IH5 A 600 (-4.7A) None	0.29A	4lnwA-1navA: 37.5	4lnwA-1navA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNX_A_T3A502_1 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	12 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 ALA A 263 LEU A 276 SER A 277 LEU A 292 ILE A 299 HIS A 381 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-4.3A) IH5 A 600 (-4.7A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.78A	4lnxA-1navA: 37.5	4lnxA-1navA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNX_A_T3A502_1 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 ALA A 225 LEU A 292 ILE A 377 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A) None IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.29A	4lnxA-1navA: 37.5	4lnxA-1navA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LNX_A_T3A502_2 (THYROID HORMONE RECEPTOR ALPHA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	3 / 3	ILE A 221 MET A 259 ARG A 262	None IH5 A 600 (-4.7A) None	0.26A	4lnxA-1navA: 37.5	4lnxA-1navA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XTA_A_DIFA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	4 / 9	SER A 260 ALA A 263 LEU A 287 ILE A 222	IH5 A 600 ( 4.0A) IH5 A 600 ( 3.8A) None IH5 A 600 (-4.3A)	0.86A	4xtaA-1navA: 22.6	4xtaA-1navA: 28.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XTA_A_DIFA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	4 / 9	SER A 260 ALA A 263 LEU A 292 ILE A 222	IH5 A 600 ( 4.0A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.7A) IH5 A 600 (-4.3A)	0.97A	4xtaA-1navA: 22.6	4xtaA-1navA: 28.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZO1_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	10 / 12	ILE A 222 ALA A 225 ARG A 228 MET A 256 MET A 259 ALA A 263 LEU A 276 HIS A 381 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 (-3.5A) IH5 A 600 (-4.2A) IH5 A 600 (-3.6A) IH5 A 600 (-4.7A) IH5 A 600 ( 3.8A) IH5 A 600 (-4.0A) IH5 A 600 (-3.7A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	0.75A	4zo1X-1navA: 37.4	4zo1X-1navA: 81.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZO1_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	6 / 12	ILE A 222 ALA A 263 ARG A 266 LEU A 276 MET A 388 PHE A 401	IH5 A 600 (-4.3A) IH5 A 600 ( 3.8A) None IH5 A 600 (-4.0A) IH5 A 600 (-3.8A) IH5 A 600 (-4.4A)	1.13A	4zo1X-1navA: 37.4	4zo1X-1navA: 81.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OG9_A_TESA503_1 (-)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	5 / 9	LEU A 287 LEU A 276 MET A 388 ALA A 225 MET A 259	None IH5 A 600 (-4.0A) IH5 A 600 (-3.8A) IH5 A 600 (-3.5A) IH5 A 600 (-4.7A)	1.30A	5og9A-1navA: undetectable	5og9A-1navA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINA SE)	1nav	HORMONE RECEPTOR ALPHA 1, THRA1 (Homo sapiens)	5 / 12	LEU A 276 THR A 219 LEU A 292 HIS A 381 MET A 256	IH5 A 600 (-4.0A) IH5 A 600 (-4.6A) IH5 A 600 (-4.7A) IH5 A 600 (-3.7A) IH5 A 600 (-3.6A)	1.36A	5utuF-1navA: undetectable	5utuF-1navA: 21.73

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BSX_A_T3A1_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 221;ILE A 222;ARG A 228;MET A 256;MET A 259;ALA A 263;LEU A 276;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.66A","1bsxA-1navA:37.4",null],["1BSX_A_T3A1_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;MET A 259;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.44A","1bsxA-1navA:37.4","1bsxA-1navA:83.08"],["1BSX_B_T3B2_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 221;ILE A 222;ARG A 228;MET A 256;MET A 259;ALA A 263;LEU A 276;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.66A","1bsxB-1navA:37.5","1bsxA-1navA:83.08"],["1BSX_B_T3B2_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;MET A 259;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.44A","1bsxB-1navA:37.5","1bsxB-1navA:83.08"],["1XZX_X_T3X500_1","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 221;ILE A 222;ALA A 225;ARG A 228;MET A 256;MET A 259;LEU A 276;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 (-4.0A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.69A","1xzxX-1navA:37.1","1bsxB-1navA:83.08"],["1XZX_X_T3X500_1","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",7,"ILE A 222;ALA A 225;MET A 259;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.25A","1xzxX-1navA:37.1","1xzxX-1navA:83.21"],["1Y0X_X_T44X500_1","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",11,"ILE A 222;ALA A 225;ARG A 228;MET A 256;MET A 259;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401;PHE A 405","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A);None","0.71A","1y0xX-1navA:37.3","1xzxX-1navA:83.21"],["1Y0X_X_T44X500_1","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",9,"ILE A 222;ALA A 225;ARG A 266;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401;PHE A 405","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);None;IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A);None","0.79A","1y0xX-1navA:37.3","1y0xX-1navA:83.21"],["1Y0X_X_T44X500_1","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",7,"ILE A 222;ALA A 225;MET A 259;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.27A","1y0xX-1navA:37.3","1y0xX-1navA:83.21"],["1Y0X_X_T44X500_2","THYROID HORMONE RECEPTOR BETA-1","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",4,"ILE A 221;SER A 260;ARG A 262;LEU A 276","None;IH5 A 600 ( 4.0A);None;IH5 A 600 (-4.0A)","0.21A","1y0xX-1navA:37.3","1y0xX-1navA:83.21"],["2H77_A_T3A1_1","THRA PROTEIN","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 222;ALA A 225;ARG A 228;MET A 256;MET A 259;ALA A 263;LEU A 276;SER A 277;LEU A 292;ILE A 299;HIS A 381;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-4.4A)","0.71A","2h77A-1navA:37.8","1y0xX-1navA:83.21"],["2H77_A_T3A1_1","THRA PROTEIN","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;ALA A 225;MET A 259;LEU A 292;ILE A 377;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-4.4A)","1.35A","2h77A-1navA:37.8","2h77A-1navA:99.62"],["2H79_A_T3A1_1","THRA PROTEIN","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",11,"ILE A 221;ILE A 222;ALA A 225;MET A 256;ALA A 263;LEU A 276;SER A 277;LEU A 292;ILE A 299;HIS A 381;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-3.6A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-4.4A)","0.42A","2h79A-1navA:37.5","2h77A-1navA:99.62"],["2H79_A_T3A1_1","THRA PROTEIN","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",11,"ILE A 222;ALA A 225;ARG A 228;MET A 256;ALA A 263;LEU A 276;SER A 277;LEU A 292;ILE A 299;HIS A 381;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-4.4A)","0.68A","2h79A-1navA:37.5","2h79A-1navA:99.62"],["3GWS_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",7,"ALA A 225;ARG A 228;ALA A 263;LEU A 276;LEU A 292;ILE A 299;PHE A 405","IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None","1.49A","3gwsX-1navA:37.2","2h79A-1navA:99.62"],["3GWS_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 221;ILE A 222;ALA A 225;ARG A 228;MET A 256;MET A 259;ALA A 263;LEU A 276;LEU A 292;ILE A 299;HIS A 381;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-4.4A)","0.66A","3gwsX-1navA:37.2","3gwsX-1navA:83.01"],["3GWS_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;ALA A 225;MET A 259;LEU A 292;ILE A 377;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);None;IH5 A 600 (-4.4A)","1.31A","3gwsX-1navA:37.2","3gwsX-1navA:83.01"],["3IV6_B_SAMB301_0","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",5,"GLY A 303;ILE A 299;ASP A 268;LEU A 274;ARG A 266","None;IH5 A 600 (-4.7A);None;None;None","1.33A","3iv6B-1navA:undetectable","3gwsX-1navA:83.01"],["3UVV_A_T3A501_1","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 221;ILE A 222;ALA A 225;MET A 256;ALA A 263;LEU A 276;LEU A 287;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","None;IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-3.6A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);None;IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.51A","3uvvA-1navA:36.4","3iv6B-1navA:23.53"],["3UVV_A_T3A501_2","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",3,"ARG A 228;MET A 259;ARG A 262","IH5 A 600 (-4.2A);IH5 A 600 (-4.7A);None","0.49A","3uvvA-1navA:36.4","3uvvA-1navA:90.87"],["4LNW_A_T3A501_1","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 222;ALA A 225;ARG A 228;MET A 256;ALA A 263;LEU A 276;SER A 277;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.77A","4lnwA-1navA:37.5","3uvvA-1navA:90.87"],["4LNW_A_T3A501_1","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;ALA A 225;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.28A","4lnwA-1navA:37.5","4lnwA-1navA:100.00"],["4LNW_A_T3A501_2","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",3,"ILE A 221;MET A 259;ARG A 262","None;IH5 A 600 (-4.7A);None","0.29A","4lnwA-1navA:37.5","4lnwA-1navA:100.00"],["4LNX_A_T3A502_1","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",12,"ILE A 222;ALA A 225;ARG A 228;MET A 256;ALA A 263;LEU A 276;SER A 277;LEU A 292;ILE A 299;HIS A 381;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-4.3A);IH5 A 600 (-4.7A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.78A","4lnxA-1navA:37.5","4lnwA-1navA:100.00"],["4LNX_A_T3A502_1","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;ALA A 225;LEU A 292;ILE A 377;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A);None;IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.29A","4lnxA-1navA:37.5","4lnxA-1navA:100.00"],["4LNX_A_T3A502_2","THYROID HORMONE RECEPTOR ALPHA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",3,"ILE A 221;MET A 259;ARG A 262","None;IH5 A 600 (-4.7A);None","0.26A","4lnxA-1navA:37.5","4lnxA-1navA:100.00"],["4XTA_A_DIFA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",4,"SER A 260;ALA A 263;LEU A 287;ILE A 222","IH5 A 600 ( 4.0A);IH5 A 600 ( 3.8A);None;IH5 A 600 (-4.3A)","0.86A","4xtaA-1navA:22.6","4lnxA-1navA:100.00"],["4XTA_A_DIFA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",4,"SER A 260;ALA A 263;LEU A 292;ILE A 222","IH5 A 600 ( 4.0A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.7A);IH5 A 600 (-4.3A)","0.97A","4xtaA-1navA:22.6","4xtaA-1navA:28.96"],["4ZO1_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",10,"ILE A 222;ALA A 225;ARG A 228;MET A 256;MET A 259;ALA A 263;LEU A 276;HIS A 381;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 (-3.5A);IH5 A 600 (-4.2A);IH5 A 600 (-3.6A);IH5 A 600 (-4.7A);IH5 A 600 ( 3.8A);IH5 A 600 (-4.0A);IH5 A 600 (-3.7A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","0.75A","4zo1X-1navA:37.4","4xtaA-1navA:28.96"],["4ZO1_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",6,"ILE A 222;ALA A 263;ARG A 266;LEU A 276;MET A 388;PHE A 401","IH5 A 600 (-4.3A);IH5 A 600 ( 3.8A);None;IH5 A 600 (-4.0A);IH5 A 600 (-3.8A);IH5 A 600 (-4.4A)","1.13A","4zo1X-1navA:37.4","4zo1X-1navA:81.68"],["5OG9_A_TESA503_1","-","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",5,"LEU A 287;LEU A 276;MET A 388;ALA A 225;MET A 259","None;IH5 A 600 (-4.0A);IH5 A 600 (-3.8A);IH5 A 600 (-3.5A);IH5 A 600 (-4.7A)","1.30A","5og9A-1navA:undetectable","4zo1X-1navA:81.68"],["5UTU_F_ADNF503_1","ADENOSYLHOMOCYSTEINASE","1nav","HORMONE RECEPTOR ALPHA 1, THRA1","Homo sapiens",5,"LEU A 276;THR A 219;LEU A 292;HIS A 381;MET A 256","IH5 A 600 (-4.0A);IH5 A 600 (-4.6A);IH5 A 600 (-4.7A);IH5 A 600 (-3.7A);IH5 A 600 (-3.6A)","1.36A","5utuF-1navA:undetectable","5og9A-1navA:21.41"]]